NATHAN NEPO: Open Payments
NPI 1194416255 · MISSION HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 37 payments from 15 companies in 2025. Trend: 2023 $308 · 2024 $2,165 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $282 |
| ABBVIE INC. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| GlaxoSmithKline, LLC. | 3 | $81 |
| Calliditas Therapeutics US Inc. | 3 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Aurinia Pharma U.S., Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
Products named: TAVNEOS, DALVANCE, JYNARQUE, KRYSTEXXA, TARPEYO, BENLYSTA, LOKELMA, Kerendia.
Industry payments across CA — which companies pay providers there.
